Skip to main content
HK inno.N Corporation logo

HK inno.N Corporation — Investor Relations & Filings

Ticker · 195940 ISIN · KR7195940002 KO Manufacturing
Open in API
Filings indexed 256 across all filing types
Latest filing 2024-03-28 Board/Management Inform…
Country KR South Korea
Listing KO 195940

About HK inno.N Corporation

https://www.inno-n.com/eng

HK inno.N Corporation is a biohealth company engaged in the development, manufacturing, and distribution of pharmaceutical and consumer healthcare products. The company operates through two main divisions: Specialty Medicines and Health & Beauty (H&B). The Specialty Medicines division focuses on prescription drugs, with research and development centered on novel treatments for gastrointestinal diseases, immune diseases, and cancer. Its bio-research efforts also include vaccines and next-generation cell and gene therapies. The Health & Beauty division provides consumer products such as health functional foods and beauty items, supported by dedicated research into new materials and ingredients. The company leverages its integrated R&D capabilities to offer innovative solutions across both its pharmaceutical and consumer health markets.

Recent filings

Filing Released Lang Actions
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment or dismissal of outside directors ('사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고'). This type of filing specifically concerns changes in the composition of the board of directors, which falls under the 'Board/Management Information' category.
2024-03-28 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing titled 'Audit Report Submission' (감사보고서 제출) from HK inno.N. It provides the audit opinion (unqualified/proper), key financial data, and auditor information as required by regulatory standards. While it contains financial data, it is a summary disclosure of the audit results rather than the full Annual Report (10-K) or a standalone audit report document (AR). In the context of Korean regulatory filings (DART), this specific format is a standard disclosure announcement regarding the submission of the audit report. FY 2023
2024-03-20 Korean
사업보고서 (2023.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Business Report' (사업보고서) for the 10th fiscal year (2023), covering the period from January 1, 2023, to December 31, 2023. It includes detailed financial statements, management discussion and analysis, corporate governance, and business operations. This aligns with the definition of an Annual Report (10-K) in the provided schema, as it is the official yearly report covering company activity and full financial performance. FY 2023
2024-03-20 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from HK inno.N regarding a decision on cash dividends. It specifies the dividend amount per share, the dividend record date, the payment date, and the approval process via the general meeting of shareholders. This aligns perfectly with the definition of a 'Notice of Dividend Amount' (DIV).
2024-03-12 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by HK inno.N. It details the date, location, and agenda items for the upcoming Annual General Meeting, including the approval of financial statements, election of directors, and remuneration limits. This type of document is a standard proxy solicitation and information statement provided to shareholders to inform them of meeting details and agenda items prior to the event.
2024-03-12 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for HK inno.N Corporation. It contains the agenda for the meeting, including the approval of financial statements, election of directors, and dividend proposals. It also includes detailed management information, such as board activity reports, director remuneration, and business overviews, which are standard components of proxy solicitation materials provided to shareholders ahead of an AGM. Therefore, it is classified as a Proxy Solicitation & Information Statement.
2024-03-12 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.